The CEO of Pfizer received loud boos when he was introduced by Donald Trump at a Black History Month event at the White House ...

President Donald Trump hosted several Black leaders, activists and entertainers at the White House for the Black History ...

Kash Patel became the first Indian-origin and openly Hindu person to be appointed as FBI director. The 44-year-old was ...

“We remain proud that our scientific breakthroughs played a significant role in getting the global health crisis under control,” said Pfizer's chief executive, Albert Bourla (pictured above ...

In 2021, a series of significant deals were signed ... More recently, Fortune reported Albert Bourla, CEO of Pfizer, as stating that he had high hopes for collaboration with Chinese biotechs ...

As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...

Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy ...

Hours after pledging that the safety net program “isn’t going to be touched,” Trump surprised some of his own staff Wednesday ...